RELATED ATTORNEYS

Samuel T. Lockner

Carlson Caspers represented Teva in a dispute over its efforts to introduce a generic version of FocalinĀ® (dexmethylphenidate) into the consumer market in this ANDA patent litigation. We achieved a successful settlement on behalf of our client.